Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 58, Issue 12, Pages 1649-1657
Publisher
Oxford University Press (OUP)
Online
2014-03-20
DOI
10.1093/cid/ciu185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
- (2013) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2012) James B Galloway et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
- (2012) Kalle J. Aaltonen et al. PLoS One
- Infections and Biologic Therapy in Rheumatoid Arthritis
- (2012) Kevin L. Winthrop RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
- (2012) J. Listing et al. RHEUMATOLOGY
- Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis
- (2012) S. Mori et al. RHEUMATOLOGY
- Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials
- (2011) Andrew E. Thompson et al. ARTHRITIS AND RHEUMATISM
- Established rheumatoid arthritis: Rationale for best practice – Physicians’ perspective of how to realise tight control in clinical practice
- (2011) S.C. Horton et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Anti-TNF therapy
- (2011) Nishanthi Thalayasingam et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
- (2010) X. Mariette et al. RHEUMATOLOGY
- Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry
- (2009) J D Greenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
- (2009) J. A. Singh et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- What is “quality of evidence” and why is it important to clinicians?
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now